Viral load and symptomatic picture
Is there any relationship between the viral load of exposure and contamination, in number of viruses and contamination processes, and the symptomatic picture in health professionals and directly linked to the fight against Coronavirus? If so, what percentage of cases and symptoms? Could these results suggest a process of controlled exposure of health agents outside the risk range and removal of those within the risk range, in order to detail the effects of contamination?
Transgenic strains from Covid-19
Covid-19A1 - Would it be possible to insert the mRNA to form the elements of the human antibody to Covid-19 in the virus itself, thus generating a variety that could promote the generation of antibodies even in the infected tissues other than lymphocytes, in addition to reproduction itself? Would this generate new viral generations in the midst of antibodies that could already mark them and facilitate defense by the body when they spread through the tissues?
Covid-19R1 - Would it be possible to insert the mRNA to form the elements of an RNAse for Covid-19, in order to reduce the impact of viral reproduction, by destruction of the viral RNA by RNAse?
Covid-19C1 - Would it be possible to insert mRNA to form elements of a Cytokinase that could promote the degeneration of excess cytokines by controlling the immune response in critically ill patients?
Would it be possible to generate the three varieties and thus use them associated according to the case? As an example, the Covid-19A1 and Covid-19R1 varieties?
The idea is to use the mechanism of the virus itself given its transmission capacity and thus promote exposure of the population to transgenic varieties under control.
Is there a way to predict the effects and lifespan of Cytokinase, so as not to compromise the immune system? Would therapy be possible and necessary if the Covid-19C1 variety is used in patients in this regard?
- Badges
- Science topic
- Similar topics
- Biological Science
- Immunology
- Antibodies